Regulation of Adiposity and Obesity Risk By Dietary Calcium: Mechanisms and Implications

Journal of the American College of Nutrition

Volumn 21, Issue 2, 2002, Pages 146S-151S

  Zemel, Michael B ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Adipocyte; Calcium; Dairy; Obesity; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; CARRIER PROTEIN; FATTY ACID; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; PROTEIN; CALCIUM ION;

ADIPOCYTE; ADIPOSE TISSUE; BODY COMPOSITION; CALCIUM INTAKE; CALORIC INTAKE; CHEMISTRY; DAIRY PRODUCT; DRUG EFFECT; FECES; HUMAN; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW; RISK FACTOR; WEIGHT REDUCTION; BODY FAT; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CALORIC RESTRICTION; CLINICAL TRIAL; CONFERENCE PAPER; ENERGY METABOLISM; EPIDEMIOLOGICAL DATA; GENE EXPRESSION; LIPID METABOLISM; LIPOLYSIS; NONHUMAN; RISK ASSESSMENT; THERMOGENESIS; TRANSGENIC MOUSE; WEIGHT GAIN;

ADIPOCYTES; ADIPOSE TISSUE; BODY COMPOSITION; CALCITRIOL; CALCIUM; CALCIUM, DIETARY; DAIRY PRODUCTS; ENERGY INTAKE; FATTY ACIDS; FECES; HUMANS; ION CHANNELS; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; OBESITY; PROTEINS; RISK FACTORS; WEIGHT LOSS;

AGOUTI; ANIMALIA; MUS MUSCULUS;

EID: 0036548811     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2002.10719212     Document Type: Article

References (42)

1. McCarron DA, Reusser ME: Finding consensus in the dietary calcium-blood pressure debate. J Am Coll Nutr 18: 398S-405S, 1999.
2. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin P-H, Karanja N, for the DASH Collaborative Research Group: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336: 1117-1124, 1997.
3. Svetky LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM for the DASH Research Group: Effects of dietary patterns on blood pressure. Subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 159: 285-293, 1999.
4. McCarron DA, Morris CD, Henry HJ, Stanton JL: Blood pressure and nutrient intake in the United States. Science 224: 1392-1398, 1984.
5. Fleming KH, Heimbach JT: Consumption of calcium in the U.S.: Food sources and intake levels. J Nutr 124: 1426S-1430S, 1994.
6. Andersen T, McNair P, Fogh-Andersen N, Nielsen TT, Hyldstrup L, Transbol I: Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity. Metabolism 35: 147-151, 1986.
7. Lind L, Lithell H, Hvarfner A, Pollare T, Ljunghall S: The relationships between mineral metabolism, obesity and fat distribution. Eur J Clin Invest 23: 307-310, 1993.
8. Zemel MB, Shi H, Greer B, DiRienzo D, Zemel PC: Regulation of adiposity by dietary calcium. FASEB J 4: 1132-1138, 2000.
9. Kim JH, Kiefer LL, Woychik RP, Wilkison WO, Truesdale A, Ittoop O, Willard D, Nichols J, Zemel MB: Agouti regulation of intracellular calcium. Role of melanocortin receptor. Am J Physiol 272: E379-E384, 1997.
10. Zemel MB, Kim JH, Woychik RP, Michaud EJ, Kadwell SH, Patel IR, Wilkison WO: Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice. Proc Natl Acad Sci USA 92: 4733-4737, 1995.
11. Jones BH, Kim JH, Zemel MB, Woychik RP, Michaud EJ, Wilkison WO, Moustaid N: Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am J Physiol 270: E192-E196, 1996.
12. Xue BZ, Moustaid N, Wilkison WO, Zemel MB: The agouti gene product inhibits lipolysis in human adipocytes via a Ca2-dependent mechanism. FASEB J 12: 1391-1396, 1998.
13. Kim JH, Mynatt RL, Moore JW, Woychik RP, Moustaid N, Zemel MB: The effects of calcium channel blockade on agouti induced obesity. FASEB J 10: 1646-1652, 1996.
14. Ye WZ, Reis A, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G: Vitamin D receptor gene polymorphisms are associated with obesity in type II diabetic subjects with early age of onset. Eur J Endocrinol 145: 181-186, 2001.
15. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S: Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76: 370-373, 1985.
16. Zamboni G, Soffiati M, Giavarina D, Tato L: Mineral metabolism in the obese. Acta Padiatr Scand 77: 741-746, 1988.
17. Kerstetter J, Cabellero B, O'Brien K, Wurtman R, Allen L: Mineral homeostasis in obesity: Effects of euglycemic hyperinsulinemia. Metabolism 40: 707-713, 1991.
18. Andersen T, McNair P, Hyldstrup L, Fogh AN, Nielsen TT, Astrup A, Transbol I: Secondary hyperparathyroidism of morbid obesity regresses during weight reduction. Metabolism 37: 425-428, 1988.
19. Bell NH, Epstein S, Shary J, Greene V, Oexmann MJ, Shaw S: Evidence of a probably role for 25-hydroxyvitamin D in the regulation of human calcium metabolism. J Bone Miner Res 3: 489-495, 1988.
20. Epstein S, Bell NH, Shary J, Show S, Greene A, Oexmann MJ: Evidence that obesity does not influence the vitamin D-endocrine system in blacks. J Bone Miner Res 1: 181-184, 1986.
21. Kajikawa M, Ishida H, Fujimoto S, Mukai E, Nishimura M, Fujita J, Tsuura Y, Okamoto Y, Norman AW, Seino Y: An insulinotropic effect of vitamin D analog with increasing intracellular Ca2 concentration in pancreatic cells through nongenomic signal transduction. Endocrinology 140: 4706-4712, 1999.
22. Norman AW, Frankel BJ, Heldt AM, Grodsky GM: Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823-825, 1980.
23. Tanaka Y, Seino Y, Ishida M, Yamaoka K, Satomura K, Yabuuchi H, Seino Y, Imura H: Effect of 1, 25-dihydroxyvitamin D3 on insulin secretion: direct or mediated? Endocrinology 118: 1971-1976, 1986.
24. McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, Snehalatha CS, Hitman CA: Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 40: 971-975, 1997.
25. Hitman GA, Mannan N, McDermott MF, Aganna E, OgunkoladeBW, Hales CN, Boucher BJ: Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 47: 688-690, 1998.
26. Shi H, Norman AW, Okamura WH, Sen A, Zemel MB: 1, 25-dihyroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 15: 2751-2753, 2001.
27. Tornquist K, Tashjian AH: Dual action of 1, 25-dihydroxycholecalciferol on intracellular Ca2 in GH4C1 cells: evidence for effects on voltage-operated Ca2 channels and Na/Ca2 exchange. Endocrinology 124: 2765-2776, 1989.
28. Fleet JC: Vitamin D receptor: not just in the nucleus anymore. Nutr Rev 57: 60-62, 1999.
29. Shi H, DiRienzo D, Zemel MB: Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energyrestricted aP2-agouti transgenic mice. FASEB J 15: 291-293, 2001.
30. Zemel MB, Sun X, Geng X: Effects of calcium-fortified breakfast cereal on adiposity in a transgenic mouse model of obesity. FASEB J 15: A598[Abstract 480.7], 2001.
31. Zemel MB, Geng X: Dietary calcium and yogurt accelerate body fat loss secondary to caloric restriction in aP2-agouti transgenic mice. Obesity Res 9: 146S[Abstract], 2001.
32. Shah H: Effects of milk-derived bioactives: an overview. Br J Nutr 84: 3-10, 2000.
33. Pihlanto-Leppala A, Koskinen P, Piilola K, Tupasela T, Korhonen H: Antiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Dairy Res 96: 53-64, 2000.
34. Mullally M, Meisel H, Fitzgerald R: Antiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins. Int Dairy J 2: 299-303, 1997.
35. Morris K, Wang Y, Kim S, Moustaid-Moussa N: Dietary and hormonal regulation of the mammalian fatty acid synthase gene. In Moustaid-Moussa N, Berdanier CD (eds): –Nutrient-Gene Interactions in Health and Disease.— Boca Raton, FL: CRC Press, 2001.
36. Shi H, Zemel MB: 1,25-diydrixyvitamin D inhibits uncoupling protein 2 expression in human adipocytes. Obesity Res 8: 52S[Abstract], 2000.
37. Denke MA, Fox MM, Schulte MC: Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 123: 1047-1053, 1993.
38. Welberg JW, Monkelbaan JF, de Vries EG, Muskiet FA, Cats A, Oremus ET, Boersma-van EK W, van Rijsbergen H, van der Meer R, Mulder NH, et al.: Effects of supplemental dietary calcium on quantitative and qualitative fecal fat excretion in man. Ann Nutr Metab 38: 185-191, 1994.
39. Shahkhalili Y, Murset C, Meirim I, Duruz E, Guinchard S, Cavadini C, Acheson K: Calcium supplementation of chocolate: Effect on cocoa butter digestibility and blood lipids in humans. Am J Clin Nutr 73: 246-252, 2001.
40. Lin Y-C, Lyle RM, McCabe LD, McCabe GP, Weaver CM, Teegarden D: Dairy calcium is related to changes in body composition during a two-year exercise intervention in young women. J Am Coll Nutr 19: 754-760, 2000.
41. Carruth BR, Skinner JD: The role of dietary calcium and other nutrients in moderating body fat in preschool children. Int J Obes 25: 559-566, 2001.
42. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, Hinders S: Calcium intake and body weight. J Clin Endocrinol Metab 85: 4635-4638, 2000.